Every healthcare provider knows that the earlier diseases are diagnosed, the more positive the treatment outcome. Regrettably, the pandemic shook up medicine to such a degree that early identification of conditions and illnesses other than COVID were put on the back burner — and that has serious costs, both physically and financially.

Research from the Harvard School of Public Health reveals that 20% of people deferred their healthcare between 2020 and 2021. And they didn't just stop going in for routine medical care or physicals; they stopped calling their physicians at the onset of more serious and immediate symptoms and concerns, too. For countless people with progressive diseases, like some cancers, this delayed medical care significantly impacted their chance to be properly treated and, in some cases, to survive.